Where to find us at SOT 2019

March 10
A Continuing Education session chaired by EBTC's Scientific Advisory Council vice-chair Daniele Wikoff. The session, "Conducting Systematic Review in Toxicology - Why, When, How?" introduces the SR concept and features talks by EBTC Board member Emily Sena, on assessment of study quality, and EBTC Research Fellow Paul Whaley on reporting and critically appraising SRs.

March 13
EBTC's Katya Tsaioun will deliver a platform presentation on EBTC's work on off-target activity of troglitazone and rosiglitazone, analysed using evidence-based approaches in three evidence streams. This talk is part of the platform session “Safety assessment of pharmaceuticals in drug development”.

Katya will then discuss the role of systematic literature review in retrospective analysis of existing data on the example of zebrafish embryotoxicity study in the session on the utility of in vitro developmental toxicity assays and building IATAs.

CAAT and EBTC visiting scholar Dr. Sevcan Gül Akgün Olmez is presenting a poster on the results of the pilot study of EBTC’s systematic review of the zebrafish embryotoxicity test (poster board 3182).

EBTC is conducting a Tox21 working group meeting at 6 - 8 pm at the Renaissance Baltimore Harbor hotel (sponsored by Elsevier). Space is limited. Please see agenda and register here.

Other days
If you want to meet up with any of us, drop an email to either Katya Tsaioun (ktsaiou1@jhu.edu) or Paul Whaley (p.whaley@lancaster.ac.uk) - we would be pleased to say hi, and organise a meeting with any EBTC staff or collaborators participating at SOT.